Gonçalo Esteves / building capable systems Field Notes →

The Vault / Companies

Company

NeoGenesis Capital

a venture firm Peter Diamandis co-founded with Yianni Psaltis, PhD. It invests in Colossal Biosciences and in companies built on Colossal's platform.

status · researched added 29 Oct 2026 updated 29 Oct 2026 from Moonshots #288 · Moonshots #306 organizationoperator-life see it in the graph →

What it is (one line): a venture firm Peter Diamandis co-founded with Yianni Psaltis, PhD. It invests in Colossal Biosciences and in companies built on Colossal's platform.

Updated 2026-10-29. Refreshed monthly, and whenever a Moonshots with Peter Diamandis episode names it.

Why it is in this archive

Gate: named in two held episodes, with no page until now. On Moonshots #288 2:24:30 (caption "Neoenesis") the host calls it "a new company, another portfolio company… using the intersection of AI and synthetic biology to design the genotype that delivers the phenotype". On Moonshots #306 1:35:13–1:35:36 he calls it "my own fund, Neoenesis… a $200 million fund that I started with Dr. Yanni Palis. It's investing in Colossal and all the spinouts, including Warhound". That second line resolves the Aspiration: investigate row the Moonshots: the disclosures ledger ledger had carried since EP288.

Facts

item value source
Fund vehicle NeoGenesis Capital Fund I, LP. Pooled investment fund (venture). Related person: Peter Harry Diamandis, Executive Officer and Director, the only one named Form D, filed 2026-07-01, read 2026-10-29
Amount sold $33,080,000. First sale 2026-06-18. Total offering amount "Indefinite" same Form D
Launch announced 14–15 Oct 2026, "in partnership with Yianni Psaltis, PhD, investing in Colossal". Written disclosure: "We are co-founders of NeoGenesis Capital and have a financial interest in the firm" his Metatrends post, 15 Oct (read on the Peter Diamandis page)
Portfolio (its own page, 17 Oct) Colossal, Breaking, Astromech, one stealth company neogenesiscapital.com, via Colossal Biosciences
Warhound a NeoGenesis investment, said on tape. Warhound came out of stealth ~22 Oct with a $200M seed at $1.2B, from In-Q-Tel, Sequoia, 8VC, ARK, Franklin Templeton, Breyer and NeoGenesis, among others Moonshots #306 1:35:13; TechCrunch via secondary outlets (verification pass, 2026-10-29)
Independence language Lamm and Church hold no economic interest in NeoGenesis; "Colossal and its affiliates have not endorsed or sponsored the fund" neogenesiscapital.com, via Colossal Biosciences

What the tape says against the documents

  • "$200 million fund" (EP306): the Form D shows $33.08M sold with the offering size left "Indefinite". $200M may be a target, but neither the filing nor the launch post found says so. 🔴 Don't repeat the size.
  • "I think I haven't mentioned this on the pod" (EP306): it was said on EP288, described as a company.
  • Co-founder name: the caption's "Dr. Yanni Palis" is Yianni Psaltis, per the host's own post. The Form D names only Diamandis.
  • What it means for the ledger: every Colossal, Colossal spin-out or Warhound story the host reads is now a story about a company his fund holds. On the Moonshots #297 Ben Lamm guest segment that was not said. On EP306 it was, before the story.

Open

  • Is $200M the target size, and is there a Form D/A with a later amount sold?
  • The stealth portfolio company: is it Warhound?
  • Psaltis's background (not researched here).

How this page stays current

Monthly: re-check EDGAR for a Form D/A, and re-read the portfolio page. Per episode: any Colossal, Astromech, Breaking or Warhound mention gets a re-disclosure check in Moonshots: the disclosures ledger.

Related

Peter Diamandis · Colossal Biosciences · Ben Lamm · Palmer Luckey · Moonshots: the disclosures ledger

Reading rule. Anything marked unverified or on-air is a claim made on the podcast and has not been checked against a primary source yet. It stays marked until it has. Sourced numbers link to where they came from.